211 related articles for article (PubMed ID: 29084837)
1. Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen
Blom AM; Magda M; Kohl L; Shaughnessy J; Lambris JD; Ram S; Ermert D
J Immunol; 2017 Dec; 199(11):3828-3839. PubMed ID: 29084837
[TBL] [Abstract][Full Text] [Related]
2. Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic.
Shaughnessy J; Vu DM; Punjabi R; Serra-Pladevall J; DeOliveira RB; Granoff DM; Ram S
Clin Vaccine Immunol; 2014 Oct; 21(10):1452-9. PubMed ID: 25143339
[TBL] [Abstract][Full Text] [Related]
3. Defining the Binding Region in Factor H to Develop a Therapeutic Factor H-Fc Fusion Protein against Non-Typeable Haemophilus influenzae.
Wong SM; Shaughnessy J; Ram S; Akerley BJ
Front Cell Infect Microbiol; 2016; 6():40. PubMed ID: 27148489
[TBL] [Abstract][Full Text] [Related]
4. Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence.
Gustafsson MC; Lannergård J; Nilsson OR; Kristensen BM; Olsen JE; Harris CL; Ufret-Vincenty RL; Stålhammar-Carlemalm M; Lindahl G
PLoS Pathog; 2013; 9(4):e1003323. PubMed ID: 23637608
[TBL] [Abstract][Full Text] [Related]
5. Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
Ram S; Shaughnessy J; DeOliveira RB; Lewis LA; Gulati S; Rice PA
Immunobiology; 2016 Oct; 221(10):1110-23. PubMed ID: 27297292
[TBL] [Abstract][Full Text] [Related]
6. Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant
Shaughnessy J; Tran Y; Zheng B; DeOliveira RB; Gulati S; Song WC; Maclean JM; Wycoff KL; Ram S
Front Immunol; 2020; 11():583305. PubMed ID: 33193396
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Fusion Proteins Enhance
Laabei M; Colineau L; Bettoni S; Maziarz K; Ermert D; Riesbeck K; Ram S; Blom AM
Front Immunol; 2020; 11():2122. PubMed ID: 32983170
[No Abstract] [Full Text] [Related]
8. Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against
Shaughnessy J; Lewis LA; Zheng B; Carr C; Bass I; Gulati S; DeOliveira RB; Gose S; Reed GW; Botto M; Rice PA; Ram S
J Immunol; 2018 Nov; 201(9):2700-2709. PubMed ID: 30266769
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
Pandiripally V; Gregory E; Cue D
Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria.
Agrahari G; Liang Z; Glinton K; Lee SW; Ploplis VA; Castellino FJ
J Biol Chem; 2016 Apr; 291(17):9181-9. PubMed ID: 26945067
[TBL] [Abstract][Full Text] [Related]
11. A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
Shaughnessy J; Gulati S; Agarwal S; Unemo M; Ohnishi M; Su XH; Monks BG; Visintin A; Madico G; Lewis LA; Golenbock DT; Reed GW; Rice PA; Ram S
J Immunol; 2016 Feb; 196(4):1732-40. PubMed ID: 26773149
[TBL] [Abstract][Full Text] [Related]
12. An optimized Factor H-Fc fusion protein against multidrug-resistant
Shaughnessy J; Chabeda A; Tran Y; Zheng B; Nowak N; Steffens C; DeOliveira RB; Gulati S; Lewis LA; Maclean J; Moss JA; Wycoff KL; Ram S
Front Immunol; 2022; 13():975676. PubMed ID: 36110842
[TBL] [Abstract][Full Text] [Related]
13. Human IgG Increases Virulence of
Ermert D; Weckel A; Magda M; Mörgelin M; Shaughnessy J; Rice PA; Björck L; Ram S; Blom AM
J Immunol; 2018 May; 200(10):3495-3505. PubMed ID: 29626087
[No Abstract] [Full Text] [Related]
14. Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes.
Haapasalo K; Jarva H; Siljander T; Tewodros W; Vuopio-Varkila J; Jokiranta TS
Mol Microbiol; 2008 Nov; 70(3):583-94. PubMed ID: 18627465
[TBL] [Abstract][Full Text] [Related]
15. The Molecular Basis of Human IgG-Mediated Enhancement of C4b-Binding Protein Recruitment to Group A Streptococcus.
Ermert D; Laabei M; Weckel A; Mörgelin M; Lundqvist M; Björck L; Ram S; Linse S; Blom AM
Front Immunol; 2019; 10():1230. PubMed ID: 31214187
[No Abstract] [Full Text] [Related]
16. Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial two-component cluster of virulence responder/sensor (CovRS) system.
Agrahari G; Liang Z; Mayfield JA; Balsara RD; Ploplis VA; Castellino FJ
J Biol Chem; 2013 Sep; 288(38):27494-27504. PubMed ID: 23928307
[TBL] [Abstract][Full Text] [Related]
17. Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors.
Ermert D; Shaughnessy J; Joeris T; Kaplan J; Pang CJ; Kurt-Jones EA; Rice PA; Ram S; Blom AM
PLoS Pathog; 2015 Jul; 11(7):e1005043. PubMed ID: 26200783
[TBL] [Abstract][Full Text] [Related]
18. A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus.
Sage MAG; Cranmer KD; Semeraro ML; Ma S; Galkina EV; Tran Y; Wycoff KL; Sharp JA
PLoS One; 2022; 17(3):e0265774. PubMed ID: 35324969
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes- induced sepsis.
Horst SA; Linnér A; Beineke A; Lehne S; Höltje C; Hecht A; Norrby-Teglund A; Medina E; Goldmann O
J Innate Immun; 2013; 5(6):581-90. PubMed ID: 23571837
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenes.
Frick IM; Shannon O; Åkesson P; Mörgelin M; Collin M; Schmidtchen A; Björck L
J Biol Chem; 2011 Jan; 286(2):1331-40. PubMed ID: 21068386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
